Correlation Between Day One and Inhibrx
Can any of the company-specific risk be diversified away by investing in both Day One and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Inhibrx, you can compare the effects of market volatilities on Day One and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Inhibrx.
Diversification Opportunities for Day One and Inhibrx
Very weak diversification
The 3 months correlation between Day and Inhibrx is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of Day One i.e., Day One and Inhibrx go up and down completely randomly.
Pair Corralation between Day One and Inhibrx
Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to generate 0.72 times more return on investment than Inhibrx. However, Day One Biopharmaceuticals is 1.39 times less risky than Inhibrx. It trades about 0.02 of its potential returns per unit of risk. Inhibrx is currently generating about 0.0 per unit of risk. If you would invest 1,323 in Day One Biopharmaceuticals on August 31, 2024 and sell it today you would earn a total of 70.00 from holding Day One Biopharmaceuticals or generate 5.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Day One Biopharmaceuticals vs. Inhibrx
Performance |
| Timeline |
| Day One Biopharmaceu |
| Inhibrx |
Day One and Inhibrx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Day One and Inhibrx
The main advantage of trading using opposite Day One and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.| Day One vs. X4 Pharmaceuticals | Day One vs. Inozyme Pharma | Day One vs. Acumen Pharmaceuticals | Day One vs. Mereo BioPharma Group |
| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |